Literature DB >> 3701363

A case of recurrent idiopathic ophthalmoplegic neuropathy (Miller Fisher syndrome)

A H Schapira, P K Thomas.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3701363      PMCID： PMC1028784          DOI： 10.1136/jnnp.49.4.463

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  ACUTE INTERNAL AND EXTERNAL OPHTHALMOPLEGIA WITH POLYRADICULITIS OF PROBABLE VIRUS AETIOLOGY.

Authors:  F B GIBBERD; R E KELLY
Journal:  Brain       Date:  1964-12       Impact factor: 13.501

2.  Peripheral nerve conduction in Miller Fisher syndrome.

Authors:  R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

3.  The ophthalmoplegic form of the Guillain-Barre-syndrome: an immunologic study.

Authors:  P O Behan; N Geschwind
Journal:  Acta Ophthalmol (Copenh)       Date:  1973

4.  Recurrent and chronic relapsing Guillain-Barré polyneuritis.

Authors:  P K Thomas; R G Lascelles; J F Hallpike; R L Hewer
Journal:  Brain       Date:  1969       Impact factor: 13.501

5.  Proposed mechanism of ataxia in Fisher's syndrome.

Authors:  A H Ropper; B Shahani
Journal:  Arch Neurol       Date:  1983-09
  5 in total
  4 in total

1.  Bickerstaff brainstem encephalitis. A case report.

Authors:  R M Camarda; R Cammalleri; D Raimondo
Journal:  Ital J Neurol Sci       Date:  1992-03

2.  Relapsing polyneuritis following classic Miller Fisher syndrome.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

3.  High dose immunoglobulin therapy is effective in the Miller Fisher syndrome.

Authors:  U Zifko; M Drlicek; G Senautka; W Grisold
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

4.  Late central demyelination after Fischer's syndrome: MRI studies.

Authors:  X Ferrer; E Ellie; M Larrivière; B Deleplanque; A Lagueny; J Julien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.